Company intelligence / Profile preview

Bayshore Pharmaceuticals

East Brunswick, NJ, United Statesbayshoreus.com ↗

Ownership: Private
Development stage: Commercial

Overview

Bayshore Pharmaceuticals is an active U.S.-based pharmaceutical company specializing in the development, manufacturing support, marketing, and distribution of FDA-approved generic drugs. The company also provides private label services for nutraceuticals/vitamin supplements. Its portfolio includes over a dozen ANDA-approved small molecule drugs across multiple therapeutic areas. No proprietary clinical-stage assets or novel therapeutics were identified.

Therapeutic areas: ImmunologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities: Small molecules/generic drugsOver-the-counter productsNutraceuticals/vitamin supplements
Industry: Biotech

Partnerships

Works with global manufacturing partners for product registration/distribution but no specific major pharma partnerships disclosed.

Beyond the preview

Go deeper on Bayshore Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bayshore Pharmaceuticals.